Active immunotherapy trials on acute lymphoid leukemia lymphosarcoma and acute myeloid leukemia (Q40780396)

23 September 2017

title

Active immunotherapy trials on acute lymphoid leukemia lymphosarcoma and acute myeloid leukemia (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

20 March 2023

1 reference

1 reference

lymphoblastic leukemia

1 reference

1

Mathe G

1 reference

23 September 2017

G. Mathe

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326558

20 March 2023

L. Schwarzenberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326558

20 March 2023

M. Delgado

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326558

20 March 2023

F. De Vassal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326558

20 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=326558

20 March 2023

publication date

1 April 1977

1 reference

full work available at URL

23 September 2017

https://api.elsevier.com/content/article/PII:0014296477901013?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

https://api.elsevier.com/content/article/PII:0014296477901013?httpAccept=text/plain

20 March 2023

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

European Journal of Cancer

20 March 2023

published in

1 reference

23 September 2017

volume

13

1 reference

23 September 2017

issue

4-5

1 reference

23 September 2017

page(s)

445-455

1 reference

Active immunotherapy for acute lymphoblastic leukaemia

23 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Active immunotherapy of L1210 leukaemia applied after the graft of tumour cells

20 March 2023

7

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Particles with characteristics of leukoviruses in cultures of marrow cells from leukemic patients in remission and relapse

20 March 2023

13

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Treatment of Childhood Acute Lymphocytic Leukemia

20 March 2023

22

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy

20 March 2023

31

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Letter: Chemotherapy and B.C.G. in acute lymphocytic leukaemia

20 March 2023

33

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Prolonging remission in myeloblastic leukemia by tice-strain bacillus Calmette-Guérin

20 March 2023

39

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G.

20 March 2023

40

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

A second comparative trial of remission induction (by cytosine arabinoside given every 12 hours, or C.A.R. and thioguanine, or C.A.R. and daunorubicine) and maintenance therapy (by C.A.R. or methylgag) in acute myeloid leukaemia

20 March 2023

44

1 reference

https://api.crossref.org/works/10.1016/0014-2964(77)90101-3

20 March 2023

Identifiers

1 reference

23 September 2017

1 reference